Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Multi Asset Allocation median (36 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 22 Feb 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 50 history starts 18 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | SBI Multi Asset Allocation Fund |
|---|---|
| 22 Feb 2013 | ₹100.00 |
| 09 Apr 2014 | ₹101.42 |
| 24 May 2015 | ₹109.79 |
| 08 Jul 2016 | ₹114.83 |
| 22 Aug 2017 | ₹119.08 |
| 07 Oct 2018 | ₹118.41 |
| 22 Nov 2019 | ₹127.72 |
| 05 Jan 2021 | ₹149.16 |
| 20 Feb 2022 | ₹166.67 |
| 06 Apr 2023 | ₹181.22 |
| 21 May 2024 | ₹242.86 |
| 05 Jul 2025 | ₹276.39 |
| 20 Aug 2026 | ₹314.59 |
| Metric | SBI · Direct · IDCW NAV ₹33.90 High risk ★★★☆☆ | Category median Multi Asset Allocation · 36 funds |
|---|---|---|
| +14.39% | +13.66% | |
| +16.63% | +14.46% | |
| +14.54% | +13.79% | |
| +10.42% | +9.77% | |
| +8.87% | +13.06% | |
| +15.33% | — | |
| +9.20% | +9.80% | |
| +8.72% | +9.17% | |
| +8.89% | +8.75% | |
| Risk | ||
| 7.99% | 10.17% | |
| 1.27 | 0.75 | |
| 1.76 | 1.03 | |
| -17.89% | -13.10% | |
| Nifty 50 | — | |
| +7.76% | +7.76% | |
| 0.53 | 0.63 | |
| 77.9% | 83.4% | |
| 14.3% | 29.2% | |
| 0.68% | 0.78% | |
| ₹17,976Cr | ₹2,835Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 34% | 50% | |
| Dinesh Balachandran · 4.8y | — | |
| 22 Feb 2013 | — | |
| 73 | — | |
| 17.2% | — | |
| 3.7% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.